• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of May 29, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
Recall Number D-427-2013
Classification Class II
Code Info Lot # a) 64333, Exp. 5/13; 64937, Exp. 6/13; 65629, Exp. 7/13; and 66296, Exp. 9/13; b) 64931, Exp. 5/13 and 65766, Exp. 7/13
Product Distributed Qty 103,796 bottles
Reason For Recall Subpotent Drug: The products were below specification for potency at the expiry stability point.

Event Detail

Event Id 65172
Product Type Drugs
Status Ongoing
Recalling Firm King Legacy, a wholly owned subsidiary of Pfizer
City Bristol
State TN
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-04-30
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide and Puerto Rico
-
-